Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
buy vibrator. safety films
Popular Articles

Lilly Receives Fourth FDA Approval For ALIMTA(R) (pemetrexed For Injection)
Eli Lilly and Company (NYSE: LLY) announced it received a fourth approval from the U.S. Food and Drug Administration (FDA) for ALIMTA(R) (pemetrexed for injection). The latest approval is for ALIMTA as a maintenance therapy for locally advanced or metastatic non-small cell lung cancer (NSCLC), specifically for patients with a nonsquamous histology whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. ALIMTA is not indicated for treatment of patients with squamous cell non-small cell lung cancer.
pharmacy online
Innovative Treatment Approach Offers New Hope For Eczema Sufferers With Moderate To Severe Disease PROTOPIC Ointment Can Help Prevent Eczema Flares
Today sees the European launch of the first topical calcineurin inhibitor to be approved for the maintenance treatment of eczema to prevent flares and prolong flare-free intervals. PROTOPIC ointment (tacrolimus monohydrate) is already licensed to treat moderate and severe eczema (atopic dermatitis), often involving the treatment of flares as and when they occur.* It is now also approved for twice-weekly application to previously affected skin to prevent these exacerbations and prolong flare-free periods in PROTOPIC-responsive patients.ò€  Clinical studies have shown that this new approach brings significant benefits with over 40% of patients with moderate to severe eczema remaining flare-free for at least a year.1 Flares are known to place an enormous burden on patients. The International Study of Life with Atopic Eczema (ISOLATE) found that about 55% of these patients worried about the onset of their next exacerbation and that they spent on average over a third of the year (136 days) with their eczema in flare.2
News of the day
What Are Gallstones? What Causes Gallstones?
Gallstones are lumps or stones that develop in the gallbladder or bile duct. Some of the chemicals which exist in the gallbladder, such as cholesterol, calcium bilirubinate, and calcium carbonate, harden into either one large stone or many small ones. According to Medilexicon"s medical dictionary, a gallstone is "A concretion in the gallbladder or a bile duct, composed chiefly of a mixture of cholesterol, calcium bilirubinate, and calcium carbonate, occasionally as a pure stone composed of just one of these substances". An article describes a gallbladder in the bile duct similar to trying to squeeze a golf ball through a straw.
Oncology

NPR Program Features Discussions On Several Topics Related To Abortion Rights

NPR"s "Talk of the Nation" on Tuesday included a discussion with NPR health policy correspondent Julie Rovner regarding abortion-rights policies and other reproductive health-related issues under the Obama administration. Rovner also discussed a recent Gallup poll that found more U.S. residents described themselves as "pro-life" rather than "pro-choice" for the first time. Rovner noted that public opinion on abortion "tends to be countercyclical to who"s in charge." For example, when the president and the majority in Congress both oppose abortion rights, supporters of those rights "tend to get kind of riled up," she said. Similarly, abortion-rights opponents often are more vocal when abortion-rights supporters occupy the White House and control the majority in Congress, "[s]o it wouldn"t be surprising that you would see ... more of a pro-life push in opinion polls." Rovner noted that the percentage of people who believe abortion should be always illegal or always legal has not changed significantly since 1975. The discussion included Obama"s nomination of Judge Sonia Sotomayor to the Supreme Court, and his administration"s proposal to repeal the Bush administration"s HHS "conscience" rule, which expanded the ability health care workers now have to refuse to provide services they find morally or religiously objectionable. Rovner said that a finalization of the Obama administration"s proposal on the refusal rule is expected in July, although she added that repealing the rule would "likely have little practical effect" because existing statutes already protect workers with moral and religious objections. When asked about whether Obama has lived up to the expectations of abortion-rights supporters who endorsed him as a candidate, Rovner said that the president has "tried very hard to steer middle ground on this issue, to say, really, there should be a way to find peace" (Conan [1], "Talk of the Nation," NPR, 6/9).Tuesday"s program also included a discussion on how some physicians decide whether they will perform abortions and how that decision affects their lives. Guests included Suzanne Poppema, board chair of Physicians for Reproductive Choice and Health, and John Kelly, a retired surgeon who opposes abortion rights (Conan [2], "Talk of the Nation," NPR, 6/9). Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women"s Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women"s Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company. © 2009 The Advisory Board Company. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009